This site is intended for healthcare professionals
News

Phase III SAkuraStar and SAkuraSky trials of Enspryng shows efficacy in neuromyelitis optica spectrum disorder.- Genentech/Roche

Read time: 1 mins
Last updated:11th Sep 2020
Published:11th Sep 2020
Condition: Neuromyelitis Optica
Type: drug
Register free for full access to medthority.com